Cell and gene therapies are transforming healthcare, but their full potential depends on a supportive policy landscape. Join policymakers, industry leaders, and science stakeholders to explore new regulatory policy developments, payment systems, and key therapeutic bottlenecks.
Your participation is vital to building a supportive policy landscape that will unlock the full potential of gene and cell therapies.